biopharma Archives - Journal for Clinical Studies

Current Edition

Regional News

GlaxoSmithKline relocates US operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs

Many companies have shifted their way of working amid COVID-19. Adjusting to how work is done these days, GlaxoSmithKline is downsizing its office footprint in the U....

6 October 2021 Regional News biopharma | Excision BioTherapeutics

Continue Reading →

Regional News

Viatris shows no signs of growing pains in its ‘trough year,’ but one analyst has longer-term worries

Viatris CEO Michael Goettler may well consider this a “trough” year for his newly formed company. But only months after he made that declaration, Viatris reported fig...

10 August 2021 Regional News biopharma | COVID-19

Continue Reading →

Europe

Paradigm Biopharma’s clinical trials in the fast lane

Paradigm Biopharmaceuticals (ASX: PAR) is surpassing its own expectations in recruiting patients for its two phase two clinical trials, which will speed up the announ...

28 March 2018 Europe | North America biopharma | clinical

Continue Reading →

Derisking FIH Integrated Strategies

Current Edition

GlaxoSmithKline relocates US operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs

Viatris shows no signs of growing pains in its ‘trough year,’ but one analyst has longer-term worries

Paradigm Biopharma’s clinical trials in the fast lane

Journal for Clinical Studies